Gladstone Home spacer GICD
 
GICD HOME

Gladstone Institutes Home  
Institute of
Virology and
Immunology
GIVI
 
Institute of
Neurological Disease
GIND
 
Center for
Translational
Research
CTR
University of California,
San Francisco
UCSF
 
Supporting Gladstone
Nuclear Reprogramming to Induce Pluripotency

Laboratory of Shinya Yamanaka

Dr. Yamanaka is the latest addition to the GICD faculty. His laboratory studies the biology of stem cells and recently made the breakthrough discovery that a set of four factors can reprogram mature adult cells into pluripotent stem cells. These induced pluripotent stem (iPS) cells are nearly identical to embryonic stem cells and can even be used to generate live mice entirely derived from the iPS cells—a key feature of truly pluripotent cells. Dr. Yamanaka’s work has been featured in both the scientific and lay press as it offers a realistic method for deriving patient-specific human pluripotent stem cells without the ethically-debated requirement of donor oocytes or destruction of embryos. He will be pursuing the translation of his initial findings into the human system at the Gladstone Institutes.

 

Creation of induced pluripotent stem (iPS) cells from mature adult cells. Four factors, Oct4, Sox2, c-Myc, and Klf4 were introduced into adult mouse fibroblasts to generate iPS cells, which have properties nearly identical to embryonic stem cells. Images of fibroblasts, ES cells, and iPS cells show that the iPS cells more closely resemble ES cells than the parental fibroblast line from which they were derived.


The “Yamanaka Method” may be valuable to generate patient-specific iPS cell lines that one day may be used to treat disease. This method bypasses the need for donor oocytes and may directly generate human iPS cells from mature adult fibroblasts or other cell types. Patient-specific iPS cells could be expanded in culture indefinitely and differentiated into any cell type in the body or used to create organs or tissues to be reimplanted into the patient.


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF